Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Catalent has announced that it will begin the first phase of a planned $100-million expansion at its facility in Anagni, Italy to add biologics drug-substance manufacturing. The initial phase of the expansion will see the installation of two...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Batavia Biosciences and Swissfillon. Biologics Manufacturing Batavia Biosciences, RocketVax in Pact for COVID-19 VaccineBatavia Biosciences, a Leiden, the Netherlands-based...

Albany Molecular Research, Inc. (AMRI), a contract research, development and manufacturing organization, has rebranded and changed its name to Curia. Additionally, Curia has agreed to acquire Integrity Bio, a Thousand Oaks, California-based CDMO...

Fujifilm Corporation has announced it will invest a 90 billion Yen ($850 million) to expand Fujifilm Diosynth Biotechnologies, its biologics CDMO and subsidiary. The 90-billion Yen ($850-million) investment will double Fujifilm Diosynth...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Jubilant HollisterStier, BD, and Cryoport. Biologics Manufacturing Ocugen, Jubilant HollisterStier Partner for COVID-19 Vaccine MfgOcugen, a Malvern, Pennsylvania-based...